Catalent Inc (CTLT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CTLT • US1488061029

63.48 USD
0 (0%)
At close: Dec 17, 2024
63.5 USD
+0.02 (+0.03%)
After Hours: 12/17/2024, 8:52:12 PM
Fundamental Rating

3

Overall CTLT gets a fundamental rating of 3 out of 10. We evaluated CTLT against 191 industry peers in the Pharmaceuticals industry. CTLT has a bad profitability rating. Also its financial health evaluation is rather negative. CTLT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CTLT had positive earnings in the past year.
  • CTLT had a positive operating cash flow in the past year.
  • In multiple years CTLT reported negative net income over the last 5 years.
  • In the past 5 years CTLT always reported a positive cash flow from operatings.
CTLT Yearly Net Income VS EBIT VS OCF VS FCFCTLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.25%, CTLT is in the better half of the industry, outperforming 78.01% of the companies in the same industry.
  • CTLT's Return On Equity of -11.66% is fine compared to the rest of the industry. CTLT outperforms 75.92% of its industry peers.
Industry RankSector Rank
ROA -4.25%
ROE -11.66%
ROIC N/A
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
CTLT Yearly ROA, ROE, ROICCTLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • Looking at the Gross Margin, with a value of 21.82%, CTLT is in line with its industry, outperforming 51.83% of the companies in the same industry.
  • CTLT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CTLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
CTLT Yearly Profit, Operating, Gross MarginsCTLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

3

2. Health

2.1 Basic Checks

  • CTLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CTLT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CTLT has more shares outstanding
  • CTLT has a worse debt/assets ratio than last year.
CTLT Yearly Shares OutstandingCTLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTLT Yearly Total Debt VS Total AssetsCTLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • CTLT has an Altman-Z score of 1.62. This is a bad value and indicates that CTLT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CTLT (1.62) is better than 64.92% of its industry peers.
  • CTLT has a debt to FCF ratio of 49.84. This is a negative value and a sign of low solvency as CTLT would need 49.84 years to pay back of all of its debts.
  • CTLT has a Debt to FCF ratio of 49.84. This is in the better half of the industry: CTLT outperforms 78.01% of its industry peers.
  • A Debt/Equity ratio of 1.38 is on the high side and indicates that CTLT has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.38, CTLT is not doing good in the industry: 74.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 49.84
Altman-Z 1.62
ROIC/WACCN/A
WACC9.31%
CTLT Yearly LT Debt VS Equity VS FCFCTLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • CTLT has a Current Ratio of 2.51. This indicates that CTLT is financially healthy and has no problem in meeting its short term obligations.
  • CTLT has a Current ratio of 2.51. This is comparable to the rest of the industry: CTLT outperforms 46.07% of its industry peers.
  • A Quick Ratio of 1.93 indicates that CTLT should not have too much problems paying its short term obligations.
  • CTLT has a Quick ratio (1.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.93
CTLT Yearly Current Assets VS Current LiabilitesCTLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

  • CTLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.40%.
  • The earnings per share for CTLT have been decreasing by -33.48% on average. This is quite bad
  • Looking at the last year, CTLT shows a small growth in Revenue. The Revenue has grown by 4.71% in the last year.
  • Measured over the past years, CTLT shows a quite strong growth in Revenue. The Revenue has been growing by 11.71% on average per year.
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 73.38% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CTLT will show a small growth in Revenue. The Revenue will grow by 7.44% on average per year.
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTLT Yearly Revenue VS EstimatesCTLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CTLT Yearly EPS VS EstimatesCTLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

  • CTLT is valuated quite expensively with a Price/Earnings ratio of 288.55.
  • CTLT's Price/Earnings ratio is a bit cheaper when compared to the industry. CTLT is cheaper than 78.01% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, CTLT is valued quite expensively.
  • CTLT is valuated quite expensively with a Price/Forward Earnings ratio of 41.25.
  • CTLT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CTLT is cheaper than 76.44% of the companies in the same industry.
  • CTLT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 288.55
Fwd PE 41.25
CTLT Price Earnings VS Forward Price EarningsCTLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • 76.96% of the companies in the same industry are more expensive than CTLT, based on the Enterprise Value to EBITDA ratio.
  • 78.53% of the companies in the same industry are more expensive than CTLT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 116.39
EV/EBITDA 36.47
CTLT Per share dataCTLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CTLT's earnings are expected to grow with 113.64% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y148.11%
EPS Next 3Y113.64%

0

5. Dividend

5.1 Amount

  • CTLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Catalent Inc

NYSE:CTLT (12/17/2024, 8:52:12 PM)

After market: 63.5 +0.02 (+0.03%)

63.48

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05
Earnings (Next)02-07
Inst Owners92.2%
Inst Owner Change0%
Ins Owners0.48%
Ins Owner Change0%
Market Cap11.52B
Revenue(TTM)4.42B
Net Income(TTM)-413.00M
Analysts52.86
Price Target64.77 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-149.78%
Min EPS beat(2)-336.02%
Max EPS beat(2)36.46%
EPS beat(4)1
Avg EPS beat(4)-365.14%
Min EPS beat(4)-1032.86%
Max EPS beat(4)36.46%
EPS beat(8)2
Avg EPS beat(8)-208.81%
EPS beat(12)5
Avg EPS beat(12)-141.22%
EPS beat(16)9
Avg EPS beat(16)-103.51%
Revenue beat(2)1
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)4.16%
Revenue beat(4)1
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)4.16%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.33%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)0.11%
PT rev (3m)4.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.12%
EPS NY rev (1m)4.18%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.9%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 288.55
Fwd PE 41.25
P/S 2.61
P/FCF 116.39
P/OCF 28.88
P/B 3.25
P/tB 31.57
EV/EBITDA 36.47
EPS(TTM)0.22
EY0.35%
EPS(NY)1.54
Fwd EY2.42%
FCF(TTM)0.55
FCFY0.86%
OCF(TTM)2.2
OCFY3.46%
SpS24.36
BVpS19.51
TBVpS2.01
PEG (NY)0.82
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -11.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.82%
FCFM 2.24%
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 49.84
Debt/EBITDA 11.05
Cap/Depr 61.22%
Cap/Sales 6.78%
Interest Coverage N/A
Cash Conversion 90.27%
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 1.93
Altman-Z 1.62
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)125.99%
Cap/Depr(5y)159.79%
Cap/Sales(3y)11.57%
Cap/Sales(5y)13.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%
EBIT growth 1Y-166.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.68%
EBIT Next 3Y58.17%
EBIT Next 5Y41.23%
FCF growth 1Y121.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.85%
OCF growth 3Y-14.78%
OCF growth 5Y1.59%

Catalent Inc / CTLT FAQ

What is the ChartMill fundamental rating of Catalent Inc (CTLT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTLT.


What is the valuation status of Catalent Inc (CTLT) stock?

ChartMill assigns a valuation rating of 4 / 10 to Catalent Inc (CTLT). This can be considered as Fairly Valued.


Can you provide the profitability details for Catalent Inc?

Catalent Inc (CTLT) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CTLT stock?

The Price/Earnings (PE) ratio for Catalent Inc (CTLT) is 288.55 and the Price/Book (PB) ratio is 3.25.


What is the expected EPS growth for Catalent Inc (CTLT) stock?

The Earnings per Share (EPS) of Catalent Inc (CTLT) is expected to grow by 350.55% in the next year.